- Conditions
- No Evidence of Disease, Prostate Carcinoma
- Interventions
- Selenium, Placebo, Laboratory Biomarker Analysis, Pharmacological Study, Methylselenocysteine
- Dietary Supplement · Other · Drug
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 40 Years to 80 Years · Male only
- Enrollment
- 66 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2014
- U.S. locations
- 3
- States / cities
- Chicago, Illinois • Buffalo, New York • Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Nov 25, 2014 · Synced May 21, 2026, 7:49 PM EDT